CytomX Therapeutics (NASDAQ:CTMX) Price Target Raised to $5.00
CytomX Therapeutics (NASDAQ:CTMX – Free Report) had its target price increased by Piper Sandler from $2.50 to $5.00 in a report issued on Thursday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the biotechnology company’s stock. Several other analysts also recently commented on CTMX. HC Wainwright raised shares of CytomX Therapeutics from a […]
CytomX Therapeutics (NASDAQ:CTMX – Free Report) had its target price increased by Piper Sandler from $2.50 to $5.00 in a report issued on Thursday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the biotechnology company’s stock. Several other analysts also recently commented on CTMX. HC Wainwright raised shares of CytomX Therapeutics from a […]
